should we all start paying with CASH and giving “false names” on “frequent buyer discount cards” ?

Does your doctor need to know what you buy on Amazon?

Brokers are selling your data to your doctor, and no one’s regulating it.

https://www.politico.com/amp/story/2018/10/30/the-doctor-will-see-through-you-now-893437

Google, Amazon, insurers and credit card companies have long been able to tell whether you vote, own a dog, spent time in prison or drive a rusty 1997 Chevrolet. Now, that type of information is starting to pop up in front of doctors when you walk into their examination rooms.

A small but fast-growing number of technology companies, including data brokers LexisNexis and Acxiom, sell health care providers detailed analyses of their patients, incorporating criminal records, online purchasing histories, retail loyalty programs and voter registration data.

Some health systems think the data may drive better medical decision-making — helping them identify patients at risk of expensive care or rehospitalization, for instance, and enabling them to connect hurting patients with follow-up care or social work programs. The fact that a hypertension patient lives in a food desert, or lacks carfare to get to appointments, may be more important to her health than any prescription written by a doctor, former AMA President David Barbe noted in an interview.

The medical profession increasingly recognizes that it needs to be aware of how socioeconomic context — the buzz phrase is “social determinants of health” — is vital to a patient’s whole health. The flip side of benevolent concern, however, could be pigeonholing or invasions of privacy.

There are few safeguards on how such outside information can be used within the health system. The algorithms that companies use to classify some patients as “high risk” are rarely made public, so patients may not know their purchasing history or lifestyle could catapult them into a higher-risk strata. For every health plan that uses algorithms to predict substance abuse and help patients get treatment, there could be one that turns patients away when it learns they have.

Federal law protects personal health information held within the healthcare system; it doesn’t stop doctors from using outside data to learn more about how their patients live. If Congress overturns the rest of the Affordable Care Act, as Sen. Mitch McConnell has suggested, health insurers could use a patient’s grocery purchases or internet browsing history, as the basis for charging a high premium.

Even if the law doesn’t change, “there is risk that people who have personal issues at home will not seek care because combining their health data and their lifestyle data may have downstream consequences to them” such as discrimination in access to care, insurance or employment, says Crowell and Moring partner Jodi Daniel, a former HHS policy leader.

Laws and regulations don’t apply

At the moment, there’s nothing the government can do about these data uses. The FTC can crack down on data brokers for unfair or deceptive practices, but many current uses aren’t legally defined as unfair or deceptive, an agency spokesperson said.

FTC and Congress are getting interested, however, in privacy legislation that might force data brokers to share their sources or require consumer consent before gathering their data. The Senate Commerce Committee has been holding hearings that Chairman John Thune said could lead to changes in federal privacy law.

A bill introduced in April by Sens. Amy Klobuchar and John Kennedy would give consumers the right to review data collected on them and to opt out of online data collection. The FTC has held its own hearings to assess whether it needs new enforcement capabilities.

Privacy and data experts increasingly think something needs to be done, and soon. “We should consider some baseline guardrails for use of data and how to protect individuals from unintended consequences,” said Daniel. “In the meantime, I believe patients should be offered the choice” to deny insurers and doctors access to information about their lifestyles.

New laws or regulations may be needed to protect people from discrimination in employment or insurance — the way the 2008 Genetic Information Non-Discrimination Act shelters patients who undergo genetic testing from discrimination by health insurers, Daniel said. Others have called for preemptive limits on what data brokers can do with what they collect.

“Information is being provided to disparate companies for specific purposes, and then it gets in the hands of data brokers and is repurposed for things that people could never have imagined,” says Natasha Duarte, a policy analyst with the Center for Democracy & Technology. Once the information has been collected and sold, tracing a particular data point back to its origin is almost impossible, she said.

Non-voters don’t take care of themselves

The data that brokers peddle to health care providers is often wrong. Even when it isn’t, its usefulness to medicine is debatable. A recent study of 90,000 patients at the Duke University Health System concluded that putting socioeconomic data into a patient’s electronic health record didn’t improve the system’s ability to predict ER visits or hospitalizations. Apparently, doctors can figure out whether the patient in front of them is in bad shape whether the cause is an empty refrigerator or a genetic mutation.

Brokers and traders in private data are secretive about how they collect and check it for accuracy, or who buys it and for how much money.

LexisNexis has been quietly marketing a product called Socioeconomic Health Attributes that takes data from “more than 10,000 sources of public and proprietary records” and matches it to individual patients. It’s not the kind of information that normally populates a patient’s medical record.

“Liens, evictions and felonies indicate that individual health may not be a priority,” according to a marketing pitch on the company’s website. Voter registration might be relevant as well because “[i]ndividuals showing engagement in their community may be more likely to engage in their own health.”

Another LexisNexis product, Patient Identity Intelligence, can “continually update patient records with the latest demographic information,” and uses socioeconomic data to “better predict [hospital] readmission compared to models that use only clinical data,” the site says.

“We have seen providers increasingly testing and using social determinants of health over the last year to help improve their predictive modeling and care management programs,” a LexisNexis spokesperson said in an email statement, calling those providers “early adopters.”

LexisNexis would not disclose the sources of its information or how it calculates the “health risk score” it peddles to health care providers. The company directed questions about provider use to the American Medical Association, where a puzzled spokesman said the AMA had no knowledge of the matter.

A disclaimer on the LexisNexis website notes that the data flowing into its Socioeconomic Health Attributes “may contain errors.” Data from public and commercial sources are “sometimes reported or entered inaccurately, processed poorly or incorrectly, and [are] generally not free from defect.”

LexisNexis competitor CentraForce has taken another tactic: instead of selling an individual patient’s data to health care providers, it buys up large volumes of de-identified consumer survey data that includes answers to questions about trust in the medical system or substance use, as well as demographic identifiers. Providers then use the software to match patients by their demographic similarity to one of the risk categories CentraForce has established through data crunching.

The technology helps providers focus on patients whose behaviors put them at greater risk of hospital readmission or treatment failure, said Steve Newman, CentraForce’s executive chairman. He said the platform has gained traction among insurers running Medicare Advantage plans, which can lose money if their patients use up high levels of health care dollars.

Newman thinks CentraForce’s profiles are often more accurate than what patients tell their doctors.

“We know that patients will tell people in white coats different stories from what they will tell an anonymous survey company,” Newman said. “I can tell [doctors] unequivocally that the precision and accuracy of what [patients] tell us is greater than what they tell you.”

Since it doesn’t rely on personal health information to assign risk profiles, the product doesn’t require patient consent, Newman said. The company recommends that doctors use the profile to gently bring up specific health risks, “rather than in some sort of confrontational way,” he said. The added context “makes the provider, whether it’s a nurse or a physician, seem a little bit smarter, a little bit more attuned to the patient.”

Nuggets of obscure data can add up to insights, the data wranglers say. For example, “pet ownership is correlated with better outcomes. … Dogs more than cats,” says CEO Kurt Waltenbaugh of Carrot Health, which works with health plans to produce patient risk scores by crunching together medical and public records. An increase in a patient’s online purchases might suggest social isolation or poor health, he said.

But while LexisNexis and CentraForce risks scores may be mimicking the kinds of snap judgments doctors already make when they size up patients, the difference is that behavior outside the medical system may now be influencing the doctors’ judgment.

Patients often aren’t aware their information is being traded. In addition, the information that pops up in the electronic health record may be wrong or not applicable to them, said Tom Tomlinson, a privacy expert at Michigan State University’s Center for Ethics and Humanities in the Life Sciences.

Generalizations about people who don’t vote “don’t tell me whether it’s true of the person in front of me,” Tomlinson said. “What the generalization does is make me presume, without giving the patient the opportunity to prove me wrong.”

Data broker Acxiom sells data and services to identify patients eligible for community and social services based on sources such as retail history and public records. It can make detailed predictions identifying people who are likely to live with smokers even if they do not smoke, for instance, said Heidi West, its vice president for health care.

In the future the company hopes to integrate its assessments into the patient’s digital health record, West said. When it does, she hopes patients will log into Acxiom’s site to ensure their profiles are accurate. Acxiom currently has no legal requirement to do so; by correcting the profiles, individuals would be improving the data’s value to Acxiom and its clients.

West emphasized that the company wants to sell this information to providers so they can connect patients to appropriate preventive services or better tailor care. “If it even starts to go down the path of underwriting, or anything punitive, we will walk away from it,” she said.

Salesforce’s provider customers are using the software, which can integrate with EHRs, to sort patients by demographic data, including zip code, ethnicity or primary language, to refer them to relevant community health programs. “It’s the same as knowing what people’s shopping experience is,” chief medical officer Joshua Newman told POLITICO. Some providers use the software to flag patients who could benefit from counseling programs.

This type of use case attracts some physicians to the outside data. The AMA’s Barbe calls it “augmented intelligence” that could help him be a “better partner” to patients. The AMA has a project to identify the social, economic and behavioral factors most helpful to physicians treating conditions such as diabetes.

“There’s a real moral distress in taking care of people and giving them empty recommendations about what they need to do when they go home,” said physician Stacy Lindau, who created a platform matching people to local services based on their demographic data.

Socioeconomic and behavioral health information has long been used by retailers to target advertisements and services to consumers, and more recently insurers have tapped into similar data sources to flag high-risk patients. ProPublica and NPR reported on insurers partnering with data brokers to learn more about their clients’ health based on information found in the public domain.

Some data brokers have even lobbied to update HIPAA; the Claim Your Own Health Data Coalition, whose members include Experian, supported legislation to give data clearinghouses access to personal health information. The brokers say this would let them combine health data with other information and present detailed health analyses to patients, or de-identify those analyses and sell them to payers.

Digital health vendors hesitant

Cerner and Epic, the two largest electronic health records vendors, do not appear interested in incorporating background checks or detailed socio-behavioral profiles directly into their records, although they are starting to electronically connect patient records with community-based service providers.

Epic’s new release, for instance, can flag patients who might have transportation or food security issues. The company is piloting a product with researchers at the University of Wisconsin at Madison that could give clinicians detailed information about a patient’s neighborhood as part of its “precision patient engagement,” strategy, said Emily Barey, Epic’s vice president of nursing and community health.

Cerner’s vice president of population health, Marc Overhage, said the company focuses on patient-reported data, prompting patients to answer questions about their socioeconomic background when they log into their patient portals. That information can also be incorporated into scheduling systems so administrators can ask patients likely to have transportation issues if they need a ride to their appointment, for instance.

Some hospital systems, such as Providence St. Joseph Health, are testing the waters by putting basic data about income level, zip code, and food availability into patient records. But Rhonda Medows, who leads the population health team at the Washington-based system, said she has declined offers from data brokers who offer information from police records. It might be useful to know if the patient has suffered domestic violence, or a child has been at risk, but she can ask for that information from the patient.

“I’d rather have that dialogue [instead of] the police report,” she said. She doesn’t want “people to feel paranoid about tracking.”

And the idea a doctor can know things about your life outside the clinic that you haven’t told anyone else violates patient privacy and may damage trust in medicine, say critics.

If providers are only looking at cumulative risk scores, and they’re only used to “stratify people and target efforts to address social needs or impact social determinants of health on a personal or public health level, great,” said Karen DeSalvo, the former assistant secretary of health and national coordinator for health IT.

“Right now, given that ACA is still the law of the land, that data can’t be used to exclude people from coverage,” DeSalvo said said. “It gets dicey if that changes.”

Why do charge cards give people rebates for using their charge card ?  Why does a large number of retailers give you a discounted prices because you sign up for one of their frequent buyer cards ?  Should we use our real names when we subscribe to magazines or other things ?

How many/much of all these “data points” about you and your purchases being amassed , sorted and sold to various entities.

You are not required to give your legal name when signing up for these retail discount cards, or subscribe to magazine… should we being paid CASH for as many purchases as possible ?

Use cash to purchase Visa/MC/Amex/Discover cash card… and use that to make purchases anonymously.  There are numerous ways to “scramble” all the data points about you and/or your family.

Do we really want your healthcare professional to have access that you routinely purchase liquor/beer, tobacco or have a diet high in saturated fats and meat/professed meats ?

Get a VPN (virtual private network) to surf the web anonymously..  There are numerous ways to hide your real identity and there is nothing illegal about it.

Breath test detects opioids

Breath test detects opioids

https://physicsworld.com/a/breath-test-detects-opioids/

A test to detect opioid drugs in exhaled breath has been developed by engineers and physicians at the University of California, Davis. Such a breath test could be useful in caring for chronic pain patients, as well as for checking for illegal drug use (J. Breath Res. 10.1088/1752-7163/ab35fd).

“There are a few ways we think this could impact society,” says Cristina Davis, who led the research along with Michael Schivo from the UC Davis Medical Center.

Patients suffering chronic pain are commonly prescribed opioids and other analgesic drugs. Monitoring opioids and their metabolites in such patients is important to ensure that they are taking their drugs correctly, the prescribed drugs are being metabolized properly and that they are not taking any confounding medication. Blood testing is the gold standard for this, but it is invasive and requires specialized personnel to collect. Breath testing could provide a reliable, easily available and non-invasive alternative.

In this study, the researchers used a simple and non-invasive technique to collect exhaled breath condensate (EBC) from a small group of chronic pain patients at the UC Davis Medical Center. The patients received infusions of pain medication including morphine and hydromorphone, or oral doses of oxycodone.

The patients were asked to breathe normally for 15 min into a specialized collection device: a glass tube surrounded by dry ice. The droplets in breath condense and are stored in a freezer until testing. The researchers also washed the collection device with an ethanol solvent after EBC extraction to retrieve any compounds stuck to the glass surface. They analysed all of the samples using liquid chromatography coupled to mass spectrometry to identify metabolites present in the sample and  quantify the drugs being used.

After each EBC collection, blood samples were taken immediately, enabling the researchers to compare opioids and metabolites in breath with levels in blood samples and with the delivered doses. “We can see both the original drug and metabolites in exhaled breath,” Davis explains.

In this pilot study, the researchers were able to detect, quantify and identify several opioid metabolites in EBC and the subsequent ethanol solvent wash. This confirms that infused opioid drugs are present in exhaled breath, albeit in low amounts. They also found promising correlations between concentrations in blood and breath for some of the main opioids and their metabolites.

Davis notes that fully validating this breath test will require more data from larger groups of patients. Her team is now working towards real-time, bedside testing.

Right now this “breath test” is too cumbersome and takes too long ( 15 minutes ) … but… as with everything else… it becomes miniaturized and “shorter test time”… can you see cops with every traffic stop that drivers are subjected to performing this test…  To confirm the cop’s suspicion of “driving under the influence “… will any trace of opiates in such breath test start resulting in all sorts of arrests and charges against anyone legally taking a controlled substance.

Could law enforcement do data mining in the state’s PMP and start using license plate readers to target people who are legally taking opiates. Just think of all the fines imposed and collected and all the assets and cash that could be confiscated using civil asset forfeiture laws. 

Patients, Privacy, and PDMPs: Exploring the Impact of

https://livestream.com/accounts/5863524/events/8774691/player

Fund raiser : Defend Dr Joel Smithers

Defend Dr Joel Smithers

https://www.gofundme.com/f/defend-patients-rightsdefend-dr-joel-smithers

Arnold E Feldman and Angel Smithers are organizing this fundraiser on behalf of Angel Gundlach.

Dr. Joel Smithers sits in Prison, wrongfully accused, convicted and soon to be sentenced. A government scheme to Take your rights away. We must raise 50,000 dollars immediately to begin his appeal.

First they came for the Communists
but I didn’t speak because I was not a Communist
Then they came for they Trade Unionists
but I didn’t speak because I was not a Trade Unionist
Then the came for the the Jews
but I didn’t speak because I was not a Jew
Then they came for me
but there was no one left to speak for me!

Lets speak out. We do this for Dr Smithers and his family but we do this for America and our freedom.

Dr. Arnold Feldman

 

My Story: Why Isn’t My Pain Covered?

My Story: Why Isn’t My Pain Covered?

My Story: Why Isn’t My Pain Covered?

http://nationalpainreport.com/my-story-why-isnt-my-pain-covered-8841427.html

My chronic pain treatment has not been covered since the CDC guidelines were published.

But the reasons my pain is not covered are different. It’s because of what I am. I’m an older white female.

Let me explain.

I have arthritis all over the place, yes; and this is the most common debilitating pain problem in the United States. I’ve had knee replacement surgery; my hands have had multiple surgeries for they are awash in stage IV arthritis. My spine, hips, SI joints, hips and left knee all have arthritis.

I have gone to extraordinary lengths to protect my bones and joints from both arthritis and osteoporosis. I strength train rigorously every week—as I have for 30 years. I also upholster furniture, alone, with my hands. If you saw my hands you would never suspect I have severe arthritis.

I am a psychotherapist. I specialize in treating professionals with dual diagnoses: professionals with substance use disorders. I understand addiction pretty well. I also understand professionals pretty well. And I have to say today I am ashamed to be part of my profession. Not because I am like those that precipitate these feelings in me. Because I am not like them. I am a pain patient and my pain is not being covered and I am furious and terrified about it.

My pain is literally killing me. Not lessening my will to live. Not making me depressed or anxious. MY PAIN IS KILLING ME.

Since my pain stopped being properly treated, I have been incapacitated between 24-36 hours a week, every week. It is as though I entered a time warp. I am aging at an astonishingly rapid rate. It is abnormal. Since my pain has not been adequately treated my level of functioning has declined beyond any other experience with illness that I have had. I have not been able to do my taxes in four years! Never before have I been unable to do my taxes.

I believe that one of the reasons chronic pain patients have been vilified is so that addictions professionals can have more patients and make more money. And that they are currently doing just that at the same time they fail to properly treat pain. The greed that accompanies a human being’s willingness to lay claim to a patient and keep her in pain in treatment in order to make more money is pretty repulsive to me. But I believe that is one part of the puzzle. If I was not an addiction specialist, I probably would not believe this. Imagine how popular I am in my field.

I also believe this is happening because it makes the DEA feel like they have some sort of handle on the problem identified as increased death due to opioid use. In other words, DEA agents and other people in positions of responsibility for drug control blame treating pain patients for changing the social mores, the social tolerance of opioid use. If our society had not become so lax, we would not have all these overdoses. People would not dream of using heroin laced with fentanyl if the stigma had not been altered by treating pain patients with opioids.

And there is another reason, perhaps the most significant reason why this is happening. Two social groups that suffer from chronic pain the most are aging white females and people of lower Socio-Economic-Status. two social groups are comprised of human beings that are not wanted, not valued by our society. Aging white females and people of lower SES are getting bullied by the amendment and administration of the pain policies in the United States today.

I have spoken to physicians who treat pain and their response to my challenges is pretty interesting. Upon approaching one physician with a sterling reputation for treating pain with the questions I have about the failure to treat my pain properly (I have extenuating circumstances, by the way) and he made no effort whatever to answer my questions. He met me with bristling hostility. Now, I did not approach him in the manner I am writing this article. I approached him as a humble patient suffering with pain that I do not believe is being properly medicated. I asked questions articulately and perhaps without the level of meekness he would have liked. But he just bristled with hostility. There was no way IN THE WORLD he was going to address my points. Because he couldn’t. There is no justification for the way my pain is mismanaged. And he hated me for making that clear.

My pain is not being covered because I am an aging white female being put in my place.

 

 

Patients left to search for new pain care after doctors arrested

https://wtov9.com/news/local/patients-left-to-search-for-new-pain-care-after-doctor-arrested

After three doctors of area pain clinics were arrested, patients were left with no care and without medicine.

Some are having a hard time coping.

“They said sorry, good luck to you and sent me on my way,” said patient, Doug Connor.

“They told me the office is closed and they can’t see me anymore,” said another patient, Shiree Valine.

Patients of Dr. Troy Balgo discussed their concerns since his arrest last week.

Balgo is the Belmont County Coroner, and he also operates two medical clinics in St. Clairsville: Valley Medical Management of Pain and the Belmont Urgent Care Center.

DEA agents, the FBI, the Ohio Pharmacy Board and local law enforcement conducted raids at both offices, along with two other locations belonging to doctors Freeda Flynn and Thomas Romano.

Since their arrests, patients are wondering where to turn.

“I still have meds for like another week. I don’t know what it’s going to be like a week from now, but it’s not going to be a positive feeling,” said Connor.

“Lately, my hands and feet have been swelling up from not having my medication,” Valine said.

It’s tough to cope without pain relief, and even harder for their families.

“It just makes you feel some type of way because I have to watch my mom suffer,” said Valine’s son, Austin.

Rick Massatti, with the State Opioid Treatment Authority, was on scene the day of the raids. He coordinated patient care and provided a list of other providers in Ohio and West Virginia.

“We recognize some of these facilities we’re referring people to might have wait lists, not accept their insurance, might be far away, might have roadblocks, but we are committed to ensuring continuity of care with the patients,” said Massatti.

Naloxone was provided at each site during the raids.

If patients are having trouble getting into a facility, here’s the next step—

“The first person you should talk to is your family doctor. They are going to be the ones to know the resources in the areas of which they live,” Massati affirmed.

Here’s a list of pain management clinics in the Ohio area:

  • Columbiana County: Thomas & Husain Medical Associates Inc., East Liverpool, OH reached at 330-385-4004
  • Guernsey County: Michael Sayegh M.D. Cambridge, OH reached at 740-607-8296
  • Tuscarawas County: Occupational Medicine Center of Tuscarawas County, LLC. New Philadelphia, OH reached at 330-339-9211

Fox cable now up to FOUR regular contributors that are PRO-OPIATE

Rite Aid Integrates NarxCare Analytics Directly into its Pharmacist’s Workflow in 12 States

Rite Aid Integrates NarxCare Analytics Directly into its Pharmacist’s Workflow in 12 States

https://www.valdostadailytimes.com/news/business/rite-aid-integrates-narxcare-analytics-directly-into-its-pharmacist-s/article_a2e7f76a-3011-5dc4-a51a-ae5910c09459.html

Rite Aid today announced a partnership with Appriss Health, provider of the most comprehensive analytics platform for opioid stewardship and substance use disorder (SUD) in the U.S., to deploy NarxCare into clinical workflow. Rite Aid has effectively implemented NarxCare in 12 States, including all of its Pennsylvania locations.

NarxCare utilizes, analyzes, and presents information from State Prescription Drug Monitoring Programs (PDMP) to enable pharmacists to more efficiently and effectively identify and manage patients at risk for Controlled Substance Misuse and Abuse. NarxCare equips pharmacists with advanced analytics, tools, technology, and invaluable insights that are presented and accessed directly within Rite Aid’s pharmacy management system.

NarxCare also provides machine learning and artificial intelligence-based patient risk analysis in a visually interactive format to support pharmacists’ dispensing decisions and state law compliance.

“NarxCare is another efficient and effective solution to help our pharmacists make responsible dispensing decisions, while mitigating possible controlled substance misuse or abuse,”

said Jocelyn Konrad, executive vice president, pharmacy and retail operations, Rite Aid. “The integration of NarxCare and PDMP information into our pharmacist’s workflow empowers them to focus more on building relationships with patients and improving health and wellness across the communities they serve.”

“At Rite Aid, patient safety and compliance are important priorities,” said Rob Cohen, President, Appriss Health. “We applaud Rite Aid’s efforts to rapidly deploy technologies to help reduce potential customer risk by leveraging the state PDMPs, utilizing an advanced analytics platform, and integrating these solutions seamlessly into their pharmacists’ daily workflow.”

While pharmacists have access to PDMP information, it can be difficult to navigate and analyze. With NarxCare in place, pharmacists are able to identify potential problems up front, in real-time, for every customer, every time they consider a controlled substance dispensation.

Pharmacists also have the support they need to better engage with their customers and determine the best course of action for them, while fulfilling their corresponding responsibility to ensure all controlled substances are filled for a legitimate medical purpose pursuant to a valid prescription within the scope of the prescriber’s practice.

About Rite Aid Corporation

Rite Aid Corporation, which generated fiscal 2019 annual revenue of $21.6 billion, is one of the nation’s leading drugstore chains with 2,464 stores in 18 states and pharmacy benefit management (PBM) capabilities through EnvisionRxOptions and its affiliates. At Rite Aid we have a personal interest in our customers’ health and wellness and deliver the products and services they need to lead healthier lives. Information about Rite Aid, including corporate background and press releases, is available through the company’s website at www.riteaid.com.

When Appriss Health first announced the introductions of Narxcare their PR releases seems to imply that they were going to include data on a person from any and all databases they could have access to… including not only PMP’s but also and/all electronic medical/health records and many/all public records, which could include arrest and other legal records.

As of today, their website on Narxcare  https://apprisshealth.com/solutions/narxcare/ there is no mention of those other databases being accessed and/or used to come to their determination of a “abuse risk score”.

Healthcare providers and pts are still having to deal with the inability of healthcare professionals to “validate” who they are really treating.  With the prevalence of stolen/fake/forged/fabricated ID’s…  Could the data filed under those non-validated ID’s cause some legit pts to be labeled unjustly as a potential substance abuser.

We have seen what the DEA has done with the CDC opiate dosing guidelines and seemingly come to the conclusion that they are now a valid standard of care and best practices and is disregarding the statements by the CDC and FDA that those guidelines have been grossly misapplied and continuing to apply their original determination as to the appropriateness that any healthcare practitioner not following those guidelines, are in fact providing controlled substances for illegitimate reasons.

There are other alternatives that could add a layer of positive ID on a person  https://www.clearme.com/  that is being used by airports/TSA for IDing a person using digital finger prints and facial recognition.  It wouldn’t really matter whoever the person claims is their name when they first sign up for this service…they will always be that person when using that service.  This system could put a serious dent in the business plan of the serious substance abuser or diverter getting prescription opiates and controlled substances via a legal route.

If this system is good enough for the TSA/airports to ID people, why isn’t all those bureaucrats complaining about all the opiate OD’s and deaths… not considering it for healthcare ?  Unless they are really happy with the status quo ?

I want everyone to know exactly what our Drs are going through, and why so many are scared to prescribe pain meds

I want everyone to know exactly what our Drs are going through, and why so many are scared to prescribe pain meds

 

D.E.A. Let Opioid Production Surge as Crisis Grew, Justice Dept. Says

D.E.A. Let Opioid Production Surge as Crisis Grew, Justice Dept. Says

https://www.nytimes.com/2019/10/01/us/dea-opioid-crisis.html

https://www.nytimes.com/2019/10/01/us/dea-opioid-crisis.html

The Drug Enforcement Administration authorized large increases in the production of painkillers even as the number of opioid-related deaths in the United States soared, the Justice Department’s inspector general said in a harsh review on Tuesday.

The watchdog office said that the D.E.A. was “slow to respond” to the opioid crisis, adding that more than 300,000 Americans have died of opioid overdoses since 2000.

“We found that the rate of opioid overdose deaths in the United States grew, on average, by 8 percent per year from 1999 through 2013 and by 71 percent per year from 2013 through 2017,” the review said. “Yet, from 2003 through 2013 D.E.A. was authorizing manufacturers to produce substantially larger amounts of opioids.”

The D.E.A., an arm of the Justice Department, is the federal agency that most directly oversees access to opioids.

“D.E.A. is responsible for regulating opioid production quotas and investigating its illegal diversion,” Michael E. Horowitz, the inspector general, said in a video on Tuesday. “We found that D.E.A. was slow to respond to this growing public health crisis and that its regulatory and enforcement efforts could have been more effective.”

For example, he said, the agency increased production quotas for oxycodone production by about 400 percent from 2002 to 2013, despite evidence that opioids were being overprescribed and misused.

The report said the D.E.A. did not capture enough timely data on opioid abuse or other drug trends. It also noted that the agency had “recently taken steps to address the opioid epidemic, but more work remains.”

A spokeswoman for the D.E.A. said in a statement that the agency “appreciates the O.I.G.’s assessment of the programs involved in the report and the opportunity to discuss improvements made to increase the regulatory and enforcement efforts to control the diversion of opioids.”

“The D.E.A. uses a wide variety of tools — administrative, civil and criminal — to fight the diversion of controlled substances,” she added. “While only a minute fraction of the more than 1.8 million manufacturers, distributors, pharmacies and prescribers registered with D.E.A. are involved in unlawful activity, D.E.A. continuously works to identify and root out the bad actors.”

The report noted that in 2013, there was a sharp decline in the D.E.A.’s issuance of immediate suspension orders, which it called the agency’s “strongest enforcement tool” because the orders can stop companies from distributing drugs.

The agency has attributed that decline to the end of two major operations in 2012, and it said in its statement on Tuesday that it had removed about 900 registrations, which are essentially licenses to handle controlled substances, every year for the past eight years.

Andrew Kolodny, a director of opioid policy research at the Heller School for Social Policy and Management at Brandeis University who also testifies as an expert for government plaintiffs against pharmaceutical companies, said the review did not address the problems at the root of the opioid crisis — such as over-prescription of painkillers — because it was narrowly focused on the D.E.A.

“When you read the report, what you really don’t get out of it is that in almost every way in which the D.E.A. failed — except for the fact that they could have managed their data better — you have pharmaceutical industry and distributor industry influence,” he said.

The inspector general’s review comes at a critical moment in federal opioid litigation: A consolidation of nearly 2,300 cases from cities, counties and tribes nationwide seeking reparations for the epidemic.

The first trial, set to begin in Cleveland this month, pits two hard-hit Ohio counties against an array of drug manufacturers, distributors and retailers, which the plaintiffs blame for the crisis. But in laying substantial blame at the feet of the D.E.A., the inspector general has, in effect, given the drug industry defendants a powerful retort on the eve of trial.

Jan Hoffman contributed reporting.

some claim that a definition of SOCIALISM is when a bureaucracy CREATES a problem and then CREATE another/new/larger bureaucracy charged with dealing with the crisis that the bureaucracy created in the first place